Taiwan Liposome Company, Ltd. Income Statement

Ask AI

Financial Statements

In millions of TWD, except per-share amounts

	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Operating revenue
Operating expenses
General and administrative expenses
Research and development expenses
Operating expenses
Other income and expenses
Operating loss
Non-operating income and expenses
Interest income
Other gains and losses
Finance costs
Non-operating income and expenses
Loss before income tax
Income tax expense
Net loss
Items that will not be reclassified to profit or loss
Remeasurement arising on defined benefit plans
Items that may be subsequently reclassified to profit or loss
Financial statement translation differences of foreign operations
Total other comprehensive (loss) income
Total comprehensive loss
Owners of the parent
Non-controlling interests
Basic loss per share (in dollars)
Diluted loss per share (in dollars)

Comments